BTK and colitis: In stark contrast is a recent study proposing BTK as a negative regulator, based on increased intestinal inflammation in a BTK-inhibited or-deficient context (Mao et al., 2020): In this study, high LPS concentrations used for priming led to increased IL-1 release under conditions of BTK inhibition and in a colitis model, BTK deficiency was associated with greater inflammation.